Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - Cannabics Pharmaceuticals Inc. | cannabics_10q-ex3202.htm |
| EX-31.2 - CERTIFICATION - Cannabics Pharmaceuticals Inc. | cannabics_10q-ex3102.htm |
| EX-31.1 - CERTIFICATION - Cannabics Pharmaceuticals Inc. | cannabics_10q-ex3101.htm |
| 10-Q - FORM 10-Q - Cannabics Pharmaceuticals Inc. | cannabics_10q-113019.htm |
Exhibit 32.1
CERTIFICATION OF
PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of CANNABICS PHARMACEUTICALS INC. (the “Company”) on Form 10-Q for the period ended November 30, 2019, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Eyal Barad, Director and Chief Executive Officer (Principal Executive Officer) of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, that, to my knowledge:
| 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: January 14, 2020 | By: | /s/ Eyal Barad | |
| Eyal Barad | |||
|
Chief Executive Officer (Principal Executive Officer) |
|||